Asia Pharmacon Expo - 2023

ABOUT ASIA PHARMACON EXPO - 2024 EDITION

Asia Pharmacon Expo - 2024 will provide an opportunity to the participating companies to display or showcase the product among the global crowd coming from the different part of the world. The Expo will simultaneously provide opportunity to the visitors to know about the recent advancement and discoveries going on now a days. The Asia Pharmacon Expo will provide ample opportunity to all the entrepreneur to expand their business by creating a networking between various industry leaders, Investors, and global industries. Further it will also create opportunity to the startup to raise funds from various investors.

The 2 day Expo will basically focus on new labs solutions, pharmaceutical formulations, APIs, drug intermediates, contract manufacturing, Pharma and packaging machineries, software technology for pharma industry & management and other ancillary industry to Pharma, etc. The Expo will also host global speakers which will be speaking on market strategy, New FDA regulation and also on the startup culture. The visitors and exhibitors can have a direct access to highly target senior pharma executives, buyers, procurement managers, contract manufacturers, hospital administration and many more. The Expo will also witness direct selling of goods, so hospitals and organization who wants to buy bulk products can be the best options for them.

WHY EXHIBIT AT ASIA PHARMACON EXPO - 2024

An international exhibition on COMPLETE Pharma, Lab and Healthcare
Launch new products or services
Bringing together the regional buyers and international suppliers
Most effective & interactive forum to participate, explore, resource, connect and network
B2B Meetings, Business Excellence Awards
Build company or brand awareness
Demonstrate your commitment to the industry
Meet prospective new customers who are there specifically looking for solutions

INDIA PHARMA MARKET STATISTICS

India is the largest provider of generic drugs globally. Indian pharmaceutical sector supplies over 50% of global demand for various vaccines, 40% of generic demand in the US and 25% of all medicine in the UK. Globally, India ranks 3rd in terms of pharmaceutical production by volume and 14th by value. The domestic pharmaceutical industry includes a network of 3,000 drug companies and ~10,500 manufacturing units.
According to the Indian Economic Survey 2021, the domestic market is expected to grow 3x in the next decade. India's domestic pharmaceutical market is at US$ 42 billion in 2021 and likely to reach US$ 65 billion by 2024 and further expand to reach ~US$ 120-130 billion by 2030.
India's biotechnology industry comprises biopharmaceuticals, bio-services, bio-agriculture, bio-industry, and bioinformatics. The Indian biotechnology industry was valued at US$ 70.2 billion in 2020 and is expected to reach US$ 150 billion by 2025.
India's medical devices market stood at US$ 10.36 billion in FY20. The market is expected to increase at a CAGR of 37% from 2020 to 2025 to reach US$ 50 billion.
Indian pharmaceutical exports stood at US$ 24.44 billion in FY21 and US$ 22.21 billion in FY22 (until February 2022). India is the 12th largest exporter of medical goods in the world.
Medicine spending in India is projected to grow 9-12% over the next five years, leading India to become one of the top 10 countries in terms of medicine spending.

GET YOUR ENTRY PASS

Entry Fees: FREE

Facilities: